FierceBiotech ٤ يونيو ٢٠٢٦ Autobahn races toward pivotal trial after thyroid hormone mimic eases bipolar depression in ph. 2
FierceBiotech ٤ يونيو ٢٠٢٦ As China biotech crackdown calls reverberate in Washington, the pushback gets louder, too
FierceBiotech ٤ يونيو ٢٠٢٦ Innovent, fresh from $1.2B deal, posts phase 3 win for Takeda-partnered ADC
FierceBiotech ٤ يونيو ٢٠٢٦ From business strategy to CAR-T responses, for Cabaletta it’s all about ‘durability’
FierceBiotech ٤ يونيو ٢٠٢٦ Alnylam pens $2B deal with Inceptive to transform siRNA design with AI pioneer
FierceBiotech ٣ يونيو ٢٠٢٦ Lilly, Boehringer to slash at least $1B each from planned investments in Germany
FierceBiotech ٣ يونيو ٢٠٢٦ As Akeso takes center stage at ASCO, China biotech industry cements its coming of age
FierceBiotech ٣ يونيو ٢٠٢٦ Ascidian, Lilly ink RNA exon editing pact worth up to $1.9B for genetic kidney diseases
FierceBiotech ٢ يونيو ٢٠٢٦ Foundation Medicine tallies FDA nod to pair its blood test with Pfizer’s prostate cancer combo
FierceBiotech ٢ يونيو ٢٠٢٦ New heights for NewLimit as anti-aging biotech nabs $435M to rejuvenate old cells
FierceBiotech ٢ يونيو ٢٠٢٦ ASCO: Roche, head held high, details oral SERD's first-line flop in breast cancer
FierceBiotech ٢ يونيو ٢٠٢٦ Travere scales Everest with $1.1B deal for BTK inhibitor aimed at rare kidney diseases
FierceBiotech ٢ يونيو ٢٠٢٦ Fulcrum scraps SCD program, considers options after FDA takes hard line on safety risks